The JSE closed weaker on Tuesday, with its global peers mixed as investors mull further restrictions amid rising Covid-19 cases in the US and Europe. 

Monday’s news that American biotechnology group Moderna’s Covid-19 vaccine is 94.5% effective was a welcome development. But with the vaccine deployment still some time away, efforts by authorities remain focused on slowing the spread as Europe and the US grapple with rising case numbers...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now